{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:30:06Z","timestamp":1790364606046,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"October University for Modern Sciences and Arts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03330-9","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:37:30Z","timestamp":1775144250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial Intelligence-Guided Optimization of Hyaluronic Acid-Coated Liposomal Linagliptin for Targeted Management of Polycystic Ovary Syndrome"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-4144","authenticated-orcid":false,"given":"Marwa H. S.","family":"Dawoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2668-1017","authenticated-orcid":false,"given":"Aml H.","family":"Zaghloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7256-7943","authenticated-orcid":false,"given":"Karen S.","family":"Zakhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-5209","authenticated-orcid":false,"given":"Mai I.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0008-630X","authenticated-orcid":false,"given":"Zeinab M.","family":"Elnagdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6976-4561","authenticated-orcid":false,"given":"Nyera H.","family":"El-Shafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-0003","authenticated-orcid":false,"given":"Mai A.","family":"Zaafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"3330_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Dokras A, Laven J, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10:27.","journal-title":"Nat Rev Dis Primers"},{"key":"3330_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820938305","author":"MA Abdalla","year":"2020","unstructured":"Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020. https:\/\/doi.org\/10.1177\/2042018820938305.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3330_CR3","doi-asserted-by":"crossref","unstructured":"Adam L, Adam L. Comprehensive overview of polycystic ovary syndrome: pathophysiology, clinical features, and emerging therapeutic approaches. Obes Med [Internet]. 2025 [cited 2025 Nov 8];55. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2451847625000260. Accessed 8 Nov 2025.","DOI":"10.1016\/j.obmed.2025.100606"},{"key":"3330_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00109-020-01985-w","volume":"98","author":"R Paravati","year":"2020","unstructured":"Paravati R, De Mello N, Onyido EK, Francis LW, Br\u00fcsehafer K, Younas K, et al. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients. J Mol Med. 2020;98:1713\u201325. https:\/\/doi.org\/10.1007\/s00109-020-01985-w.","journal-title":"J Mol Med"},{"key":"3330_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99508-5","author":"MW Rasheed","year":"2025","unstructured":"Rasheed MW, Mahboob A, Amin L, Hussain A. Ranking polycystic ovarian syndrome (PCOS) drugs using degree-based indices in QSPR models and CRITIC-driven MCDM methods. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-99508-5.","journal-title":"Sci Rep"},{"key":"3330_CR6","doi-asserted-by":"publisher","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:1\u201317. https:\/\/doi.org\/10.1155\/2014\/719050.","DOI":"10.1155\/2014\/719050"},{"key":"3330_CR7","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/S40618-015-0372-X","volume":"38","author":"MC Amato","year":"2015","unstructured":"Amato MC, Vesco R, Vigneri E, Ciresi A, Giordano C. Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Invest. 2015;38:1319\u201326. https:\/\/doi.org\/10.1007\/S40618-015-0372-X.","journal-title":"J Endocrinol Invest"},{"key":"3330_CR8","doi-asserted-by":"publisher","unstructured":"Kumbhar PS, Chavan R, Darekar S, Kolekar K, Sequeira A, Vishwas S, et al. Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are? Naunyn Schmiedebergs Arch Pharmacol. 2025;398:3213\u201340. https:\/\/doi.org\/10.1007\/S00210-024-03578-7.","DOI":"10.1007\/S00210-024-03578-7"},{"key":"3330_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cbi.2017.06.009","volume":"273","author":"AM Kabel","year":"2017","unstructured":"Kabel AM, Al-Shehri AH, Al-Talhi RA, Abd Elmaaboud MA. The promising effect of linagliptin and\/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome. Chem Biol Interact. 2017;273:190\u20139. https:\/\/doi.org\/10.1016\/j.cbi.2017.06.009.","journal-title":"Chem Biol Interact"},{"key":"3330_CR10","doi-asserted-by":"crossref","unstructured":"Bednarz K, Kowalczyk K, Cwynar M, Czapla D, Czarkowski W, Kmita D, et al. The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome. Int J Mol Sci [Internet]. 2022 [cited 2025 Nov 8];8. https:\/\/www.mdpi.com\/1422-0067\/23\/8\/4334. Accessed 8 Nov 2025.","DOI":"10.3390\/ijms23084334"},{"key":"3330_CR11","doi-asserted-by":"publisher","unstructured":"Chen X, Wan Y, Xie L. Insulin Resistance in PCOS: pathophysiological mechanisms of menstrual dysfunction and evidence-based treatment strategies. Biol Reprod [Internet]. 2025 [cited 2025 Nov 12];ioaf197.  https:\/\/doi.org\/10.1093\/BIOLRE\/IOAF197\/8244406.","DOI":"10.1093\/BIOLRE\/IOAF197\/8244406"},{"key":"3330_CR12","doi-asserted-by":"crossref","unstructured":"Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, et al. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. J Obstet Gynaecol Res [Internet]. 2022 [cited 2025 Nov 12];61:40\u201350. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1028455921003132. Accessed 12 Nov 2025.","DOI":"10.1016\/j.tjog.2021.11.009"},{"key":"3330_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s13346-020-00839-9","volume":"11","author":"P Shah","year":"2021","unstructured":"Shah P, Chavda K, Vyas B, Patel S. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug Deliv Transl Res. 2021;11:1166\u201385. https:\/\/doi.org\/10.1007\/s13346-020-00839-9.","journal-title":"Drug Deliv Transl Res"},{"key":"3330_CR14","doi-asserted-by":"crossref","unstructured":"Pawar K, Kamble R, Patil S. Linagliptin-loaded bilosomes for oral administration: formulation, optimization by Box-Behnken design, in-vitro, and in-vivo assessment. J Drug Deliv Sci Technol [Internet]. 2025 [cited 2025 Nov 10];108:106879. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1773224725002825. Accessed 10 Nov 2025.","DOI":"10.1016\/j.jddst.2025.106879"},{"key":"3330_CR15","unstructured":"Bhikshapathi DVRN, Gadi Raju RLR. Enhancement of solubility and bioavailability of linagliptin solid dispersions by solvent evaporation technique with novel carriers. Pharmacy 2016 [conference abstract]; 2016 Jul 14\u201315; Philadelphia. Available from: https:\/\/www.scitechnol.com\/proceedings\/enhancement-of-solubility-and-bioavailability-of-linagliptin-solid-dispersions-by-solventevaporation-technique-with-nov-441.html."},{"key":"3330_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12050438","author":"J Szafraniec-Szcz\u0119sny","year":"2020","unstructured":"Szafraniec-Szcz\u0119sny J, Antosik-Rog\u00f3\u017c A, Knapik-Kowalczuk J, Kurek M, Szefer E, Gawlak K, et al. Compression-induced phase transitions of bicalutamide. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12050438.","journal-title":"Pharmaceutics"},{"key":"3330_CR17","doi-asserted-by":"crossref","unstructured":"Sweed NM, Elbalkiny HT, Magdy E, Ramadan M, Mahmoud S, Mohamed T, et al. Optimization of Linagliptin-loaded polymersomes via response surface methodology: A repurposed therapeutic strategy for hepatic encephalopathy prevention. J Drug Deliv Sci Technol [Internet]. 2025 [cited 2025 Oct 26];108. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1773224725002588. Accessed 26 Oct 2025.","DOI":"10.1016\/j.jddst.2025.106855"},{"key":"3330_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/1061186X.2025.2467089","volume":"33","author":"N Nirwan","year":"2025","unstructured":"Nirwan N, Anjaneyulu YP, Sultana Y, Vohora D. Development of linagliptin-loaded liposomes using aspartic acid conjugate for bone-targeted delivery to combat osteoporosis. J Drug Target. 2025;33:1014\u201325. https:\/\/doi.org\/10.1080\/1061186X.2025.2467089.","journal-title":"J Drug Target"},{"key":"3330_CR19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00346","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00346.","journal-title":"Chem Rev"},{"key":"3330_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijpharm.2006.04.023","volume":"319","author":"MS El-Samaligy","year":"2006","unstructured":"El-Samaligy MS, Afifi NN, Mahmoud EA. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int J Pharm. 2006;319:121\u20139.","journal-title":"Int J Pharm"},{"key":"3330_CR21","unstructured":"Lasic D. Liposomes: Synthetic lipid microspheres serve as multipurpose vesicles for the delivery of drugs, genetic material and cosmetics. Am Scientist [Internet]. 1992 [cited 2015 Nov 19];80:250\u20137. https:\/\/scholar.google.com.eg\/scholar?q=liposomes%2C+synthetic+lipid+microspheres+serve+as+multipurpose+vesicles&btnG=&hl=en&as_sdt=0%2C5#0. Accessed 19 Nov 2015."},{"key":"3330_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/02652048.2024.2335166","volume":"41","author":"NM Sweed","year":"2024","unstructured":"Sweed NM, Zaafan MA, El-Bishbishy MH, Dawoud MHS. The pulmonary protective potential of vanillic acid-loaded TPGS-liposomes: modulation of miR-217\/MAPK\/NF-\u03bab signalling pathway. J Microencapsul. 2024;41:255\u201368.","journal-title":"J Microencapsul"},{"key":"3330_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"3330_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-020-2144-3","author":"AA Khan","year":"2020","unstructured":"Khan AA, Allemailem KS, Almatroodi SA, Almatroudi A, Rahmani AH. Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications. 3 Biotech. 2020. https:\/\/doi.org\/10.1007\/s13205-020-2144-3.","journal-title":"3 Biotech"},{"key":"3330_CR25","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1002\/ADHM.201600316","volume":"5","author":"H Knopf-Marques","year":"2016","unstructured":"Knopf-Marques H, Pravda M, Wolfova L, Velebny V, Schaaf P, Engin Vrana N, et al. Hyaluronic acid and its derivatives in coating and delivery systems: applications in tissue engineering, regenerative medicine and immunomodulation. Adv Healthc Mater. 2016;5:2841\u201355. https:\/\/doi.org\/10.1002\/ADHM.201600316.","journal-title":"Adv Healthc Mater"},{"key":"3330_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01105","author":"KN How","year":"2020","unstructured":"How KN, Yap WH, Lim CLH, Goh BH, Lai ZW. Hyaluronic acid-mediated drug delivery system targeting for inflammatory skin diseases: a mini review. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.01105.","journal-title":"Front Pharmacol"},{"key":"3330_CR27","first-page":"204","volume":"13","author":"SK Kuna","year":"2023","unstructured":"Kuna SK, Choppala AD. Biocompatible osimertinib nanoliposomes coated with PEGylated hyaluronic acid enhanced tumor selectivity and cytotoxicity via CD44-mediated NSCLC targeting: development, characterization and in-vitro biochemical studies. J Appl Pharm Sci. 2023;13:204\u201313.","journal-title":"J Appl Pharm Sci"},{"key":"3330_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jconrel.2023.03.049","volume":"357","author":"C Ni","year":"2023","unstructured":"Ni C, Zhang Z, Wang Y, Zhang Z, Guo X, Lv H. Hyaluronic acid and HA-modified cationic liposomes for promoting skin penetration and retention. J Control Release. 2023;357:432\u201343. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.049.","journal-title":"J Control Release"},{"key":"3330_CR29","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(20)30226-9","volume":"395","author":"N Schwalbe","year":"2020","unstructured":"Schwalbe N, Wahl B. Artificial intelligence and the future of global health. Lancet. 2020;395:1579\u201386.","journal-title":"Lancet"},{"key":"3330_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101328","author":"DR Serrano","year":"2024","unstructured":"Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16101328. (Multidisciplinary Digital Publishing Institute (MDPI)).","journal-title":"Pharmaceutics"},{"key":"3330_CR31","doi-asserted-by":"publisher","unstructured":"Dey H, Arya N, Mathur H, Chatterjee N, Jadon R. Exploring the Role of Artificial Intelligence and Machine Learning in Pharmaceutical Formulation Design. Int J Newgen Res Pharm Healthcare. 2024;30\u201341.https:\/\/doi.org\/10.61554\/ijnrph.v2i1.2024.67. Lloyd Institute of Management and Technology.","DOI":"10.61554\/ijnrph.v2i1.2024.67"},{"key":"3330_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/math12162553","author":"F Bolikulov","year":"2024","unstructured":"Bolikulov F, Nasimov R, Rashidov A, Akhmedov F, Cho YI. Effective methods of categorical data encoding for artificial intelligence algorithms. Mathematics. 2024. https:\/\/doi.org\/10.3390\/math12162553.","journal-title":"Mathematics"},{"key":"3330_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10837450.2021.1980009","volume":"0","author":"MHS Dawoud","year":"2021","unstructured":"Dawoud MHS, Fayez AM, Mohamed RA, Sweed NM. Optimization of nanovesicular carriers of a poorly soluble drug using factorial design methodology and artificial neural network by applying quality by design approach. Pharm Dev Technol. 2021;0:1\u201350. https:\/\/doi.org\/10.1080\/10837450.2021.1980009.","journal-title":"Pharm Dev Technol"},{"key":"3330_CR34","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02609-5","volume":"24","author":"MHS Dawoud","year":"2023","unstructured":"Dawoud MHS, Mannaa IS, Abdel-Daim A, Sweed NM. Integrating artificial intelligence with quality by design in the formulation of lecithin\/chitosan nanoparticles of a poorly water-soluble drug. AAPS PharmSciTech. 2023;24:169. https:\/\/doi.org\/10.1208\/s12249-023-02609-5.","journal-title":"AAPS PharmSciTech"},{"key":"3330_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/J.EJPB.2013.06.003","volume":"85","author":"S Arpicco","year":"2013","unstructured":"Arpicco S, Lerda C, Dalla Pozza E, Costanzo C, Tsapis N, Stella B, et al. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm. 2013;85:373\u201380. https:\/\/doi.org\/10.1016\/J.EJPB.2013.06.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"3330_CR36","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1021\/nn405839n","volume":"8","author":"HSS Qhattal","year":"2014","unstructured":"Qhattal HSS, Hye T, Alali A, Liu X. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano. 2014;8:5423\u201340. https:\/\/doi.org\/10.1021\/nn405839n.","journal-title":"ACS Nano"},{"key":"3330_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/08982100802129372","volume":"18","author":"MJW Johnston","year":"2008","unstructured":"Johnston MJW, Edwards K, Karlsson G, Cullis PR. Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. J Liposome Res. 2008;18:145\u201357. https:\/\/doi.org\/10.1080\/08982100802129372.","journal-title":"J Liposome Res"},{"key":"3330_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2015.1136632","author":"P Goos","year":"2016","unstructured":"Goos P, Jones B, Syafitri U. I-optimal design of mixture experiments. J Am Stat Assoc. 2016. https:\/\/doi.org\/10.1080\/01621459.2015.1136632.","journal-title":"J Am Stat Assoc"},{"key":"3330_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/jpp\/rgaf079","author":"OF Hassan","year":"2025","unstructured":"Hassan OF, Dawoud MHS, Ibrahim SM. Selenium and iron oxide nanoparticles mitigate doxorubicin-induced cardiomyopathy in rats via Nox1\/p53 pathway inhibition. J Pharm Pharmacol. 2025. https:\/\/doi.org\/10.1093\/jpp\/rgaf079.","journal-title":"J Pharm Pharmacol"},{"key":"3330_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-022-09698-y","author":"MHS Dawoud","year":"2023","unstructured":"Dawoud MHS, Abdel-Daim A, Nour MS, Sweed NM. A quality by design paradigm for albumin-based nanoparticles: formulation optimization and enhancement of the antitumor activity. J Pharm Innov. 2023. https:\/\/doi.org\/10.1007\/s12247-022-09698-y.","journal-title":"J Pharm Innov"},{"key":"3330_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52143-y","author":"NM Sweed","year":"2024","unstructured":"Sweed NM, Dawoud MHS, Aborehab NM, Ezzat SM. An approach for an enhanced anticancer activity of ferulic acid-loaded polymeric micelles via MicroRNA-221 mediated activation of TP53INP1 in caco-2 cell line. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-52143-y.","journal-title":"Sci Rep"},{"key":"3330_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106787","author":"MHS Dawoud","year":"2025","unstructured":"Dawoud MHS, Elbalkiny HT, Gharib YEM, Fakkar SAA, Saber R, Yanni ME, et al. Beyond erectile dysfunction: optimization of vardenafil dihydrochloride for hepatic encephalopathy prophylaxis using hybrid lipid polymeric nanoparticles formulation. J Drug Deliv Sci Technol. 2025. https:\/\/doi.org\/10.1016\/j.jddst.2025.106787.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3330_CR43","doi-asserted-by":"crossref","unstructured":"Dandekar, Dandekar, Manoj P., Manasi Tadas, Srilakshmi Satthi, Aditi Jangli, et al. Oxyberberine revokes letrozole-induced polycystic ovarian syndrome and depression-like behavior in female Sprague-Dawley rats. Eur J Pharmacol [Internet]. 2025 [cited 2025 Nov 10];997:177613. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S001429992500367X. Accessed 10 Nov 2025.","DOI":"10.1016\/j.ejphar.2025.177613"},{"key":"3330_CR44","doi-asserted-by":"publisher","unstructured":"Folasade Omobolanle A, Oluwatobi Olayiwola Y, Damilola Ayodeji B, Marcus Olaoye I, Mariam Olayinka A, George Adetomiwa E. Linagliptin Efficacy on Hyperglycemia, Oxidative Stress, and Inflammation in Gestational Diabetes Mellitus. Clin J Obstet Gynecol. Heighten Science Publications Corporation: 2024;7:093\u20139.  https:\/\/doi.org\/10.29328\/journal.cjog.1001171.","DOI":"10.29328\/journal.cjog.1001171"},{"key":"3330_CR45","doi-asserted-by":"crossref","unstructured":"Antunes, Luciana C., Jessica L. Elkfury, Manoela N. Jornada, Kelly C. Foletto, Marcello C. Bertoluci. Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrinol Metab [Internet]. 2016 [cited 2025 Nov 10];60:138\u201342. https:\/\/www.scielo.br\/j\/aem\/a\/h4B3P8qNqYnRvL5vGT6rgSj\/?format=html&lang=en. Accessed 10 Nov 2025","DOI":"10.1590\/2359-3997000000169"},{"key":"3330_CR46","unstructured":"Culling C. Handbook of histopathological and histochemical techniques: including museum techniques [Internet]. 2013 [cited 2024 Dec 8]. https:\/\/books.google.com\/books?hl=en&lr=&id=HhT-BAAAQBAJ&oi=fnd&pg=PP1&dq=Handbook+of+histopathological+and+histochemical+techniques:+including+museum+techniques&ots=0IvacRMvHP&sig=6amHsgzsrl_iXeELN0ii9JBnEas. Accessed 8 Dec 2024."},{"key":"3330_CR47","doi-asserted-by":"publisher","unstructured":"Song C, Ristenpart T, Shmatikov V. Machine learning models that remember too much. Proceedings of the ACM Conference on Computer and Communications Security. Association for Computing Machinery; 2017. pp. 587\u2013601. https:\/\/doi.org\/10.1145\/3133956.3134077.","DOI":"10.1145\/3133956.3134077"},{"key":"3330_CR48","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.220028","author":"F Maleki","year":"2023","unstructured":"Maleki F, Ovens K, Gupta R, Reinhold C, Spatz A, Forghani R. Generalizability of machine learning models: quantitative evaluation of three methodological pitfalls. Radiology: Artificial Intelligence. 2023. https:\/\/doi.org\/10.1148\/ryai.220028.","journal-title":"Radiology: Artificial Intelligence"},{"key":"3330_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2017.1291672","author":"SN Politis","year":"2017","unstructured":"Politis SN, Colombo P, Colombo G, Rekkas DM. Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm. 2017. https:\/\/doi.org\/10.1080\/03639045.2017.1291672.","journal-title":"Drug Dev Ind Pharm"},{"key":"3330_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ymeth.2021.05.004","volume":"199","author":"Y Thabet","year":"2022","unstructured":"Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes: a focus on thin-film hydration method. Methods. 2022;199:9\u201315. https:\/\/doi.org\/10.1016\/j.ymeth.2021.05.004.","journal-title":"Methods"},{"key":"3330_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101518","author":"A Marinho","year":"2021","unstructured":"Marinho A, Nunes C, Reis S. Hyaluronic acid: a key ingredient in the therapy of inflammation. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11101518.","journal-title":"Biomolecules"},{"key":"3330_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","volume":"229","author":"F Ravar","year":"2016","unstructured":"Ravar F, Saadat E, Gholami M, Dehghankelishadi P, Mahdavi M, Azami S, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.012.","journal-title":"J Control Release"},{"key":"3330_CR53","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.3.5.703","author":"M Longmire","year":"2008","unstructured":"Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine. 2008. https:\/\/doi.org\/10.2217\/17435889.3.5.703.","journal-title":"Nanomedicine"},{"key":"3330_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12080763","volume":"12","author":"OK Kari","year":"2020","unstructured":"Kari OK, Tavakoli S, Parkkila P, Baan S, Savolainen R, Ruoslahti T, et al. Light-activated liposomes coated with hyaluronic acid as a potential drug delivery system. Pharmaceutics MDPI AG. 2020;12:1\u201324. https:\/\/doi.org\/10.3390\/pharmaceutics12080763.","journal-title":"Pharmaceutics MDPI AG"},{"key":"3330_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biom13010119","author":"J Liu","year":"2023","unstructured":"Liu J, Wang F, Luo F. The role of JAK\/STAT pathway in fibrotic diseases: molecular and cellular mechanisms. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13010119.","journal-title":"Biomolecules"},{"key":"3330_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1124\/dmd.109.031476","volume":"38","author":"S Blech","year":"2010","unstructured":"Blech S, Ludwig-Schwellinger E, Gr\u00e4fe-Mody EU, Withopf B, Wagner K. The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans. Drug Metab Dispos. 2010;38:667\u201378. https:\/\/doi.org\/10.1124\/dmd.109.031476.","journal-title":"Drug Metab Dispos"},{"key":"3330_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202204283","author":"HV Le","year":"2022","unstructured":"Le HV, Le Cerf D. Colloidal polyelectrolyte complexes from hyaluronic acid: preparation and biomedical applications. Small. 2022. https:\/\/doi.org\/10.1002\/smll.202204283.","journal-title":"Small"},{"key":"3330_CR58","doi-asserted-by":"crossref","unstructured":"Torchilin V. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov [Internet]. 2005 [cited 2014 Jun 26];4:145\u201360. http:\/\/www.nature.com\/nrd\/journal\/v4\/n2\/abs\/nrd1632.html. Accessed 26 Jun 2014.","DOI":"10.1038\/nrd1632"},{"key":"3330_CR59","doi-asserted-by":"publisher","DOI":"10.1023\/a:1004328601205","author":"C Hagquist","year":"1998","unstructured":"Hagquist C, Stenbeck M. Goodness of fit in regression analysis-R 2 and G 2 reconsidered. Qual Quant. 1998. https:\/\/doi.org\/10.1023\/a:1004328601205.","journal-title":"Qual Quant"},{"issue":"3","key":"3330_CR60","doi-asserted-by":"publisher","first-page":"A5","DOI":"10.1016\/j.jval.2015.03.027","volume":"18","author":"J Rigg","year":"2015","unstructured":"Rigg J, Hankins M. Reducing and quantifying over-fitting in regression models. Value Health. 2015;18:A5. https:\/\/doi.org\/10.1016\/j.jval.2015.03.027.","journal-title":"Value Health"},{"key":"3330_CR61","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3171\/2020.8.SPINE20963","volume":"34","author":"J Ehresman","year":"2021","unstructured":"Ehresman J, Lubelski D, Pennington Z, Hung B, Ahmed AK, Azad TD, et al. Utility of prediction model score: a proposed tool to standardize the performance and generalizability of clinical predictive models based on systematic review. J Neurosurg Spine. 2021;34:779\u201387. https:\/\/doi.org\/10.3171\/2020.8.SPINE20963.","journal-title":"J Neurosurg Spine"},{"key":"3330_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7324\/JAPS.2022.120617","volume":"12","author":"SH Noshi","year":"2022","unstructured":"Noshi SH, Dawoud MHS, Ibrahim MS. A quality by design approach for the optimization of olmesartan medoxomil-orodispersible lyophilisates: in vitro\/in vivo evaluation. J Appl Pharm Sci. 2022;12:175\u201385. https:\/\/doi.org\/10.7324\/JAPS.2022.120617.","journal-title":"J Appl Pharm Sci"},{"key":"3330_CR63","doi-asserted-by":"publisher","unstructured":"Renaud O, Victoria-Feser MP.\u00a0A robust coefficient of determination for regression. J Stat Plan Inference. 2010;140(7):1852\u201362. https:\/\/doi.org\/10.1016\/j.jspi.2010.01.008.","DOI":"10.1016\/j.jspi.2010.01.008"},{"key":"3330_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10020057","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10020057.","journal-title":"Pharmaceutics"},{"key":"3330_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.fochx.2025.103116","author":"L Cheng","year":"2025","unstructured":"Cheng L, Zhang M, Dong L, Wang Y, Dong J, Wu F, et al. Interaction between hyaluronic acid and phospholipid bilayer and its influence on stability and bioavailability of luteolin-loaded liposomes. Food Chem X. 2025. https:\/\/doi.org\/10.1016\/j.fochx.2025.103116.","journal-title":"Food Chem X"},{"key":"3330_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13070974","author":"A Malkawi","year":"2021","unstructured":"Malkawi A, Alrabadi N, Kennedy RA. Dual-acting zeta-potential-changing micelles for optimal mucus diffusion and enhanced cellular uptake after oral delivery. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13070974.","journal-title":"Pharmaceutics"},{"key":"3330_CR67","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12272-011-0405-8","volume":"34","author":"FH Cao","year":"2011","unstructured":"Cao FH, OuYang WQ, Wang YP, Yue PF, Li SP. A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine. Arch Pharm Res. 2011;34:551\u201362. https:\/\/doi.org\/10.1007\/s12272-011-0405-8.","journal-title":"Arch Pharm Res"},{"key":"3330_CR68","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s13346-023-01423-7","volume":"14","author":"RW Hammad","year":"2024","unstructured":"Hammad RW, Sanad RAB, Abdelmalak NS, Latif R. Cubosomal functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: recent advances in synergistic strategies for maximizing control of high-risk type II diabetes. Drug Deliv Transl Res. 2024;14:678\u201395.","journal-title":"Drug Deliv Transl Res"},{"key":"3330_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s13204-021-02018-9","author":"HA Hussein","year":"2022","unstructured":"Hussein HA, Abdullah MA. Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment. Appl Nanosci. 2022. https:\/\/doi.org\/10.1007\/s13204-021-02018-9.","journal-title":"Appl Nanosci"},{"key":"3330_CR70","doi-asserted-by":"publisher","unstructured":"Abbas A, Eissa NG, El-Bassossy HM, Ghorab MM, El Nahas HM. Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes. J Drug Deliv Sci Technol. 2024;93:105438. https:\/\/doi.org\/10.1016\/j.jddst.2024.105438.","DOI":"10.1016\/j.jddst.2024.105438"},{"key":"3330_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/app112412071","author":"C Bonechi","year":"2021","unstructured":"Bonechi C, Tamasi G, Donati A, Leone G, Consumi M, Cangeloni L, et al. Physicochemical characterization of hyaluronic acid and chitosan liposome coatings. Appl Sci. 2021. https:\/\/doi.org\/10.3390\/app112412071.","journal-title":"Appl Sci"},{"key":"3330_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-8-102","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013. https:\/\/doi.org\/10.1186\/1556-276X-8-102.","journal-title":"Nanoscale Res Lett"},{"key":"3330_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.201600228","author":"A Polomska","year":"2017","unstructured":"Polomska A, Leroux JC, Brambilla D, Wiley-VCH Verlag. Layer-by-layer coating of solid drug cores: a versatile method to improve stability, control release and tune surface properties. Macromol Biosci. 2017. https:\/\/doi.org\/10.1002\/mabi.201600228.","journal-title":"Macromol Biosci"},{"key":"3330_CR74","first-page":"646","volume":"5","author":"KK Kumar","year":"2016","unstructured":"Kumar KK, Sharma PK, Srinivas L. Development of agglomerated crystals of olmesartan medoxomil by spherical crystalization technique for enhancing the micromeritic and solubility property. World J Pharm Res. 2016;5:646\u201375.","journal-title":"World J Pharm Res"},{"key":"3330_CR75","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.biomag.2014.07.007","volume":"4","author":"H Shah","year":"2014","unstructured":"Shah H, Mahajan SR. Screening of topical gel containing lycopene and dexamethasone against UV radiation induced photoaging in mice. Biomed Aging Pathol. 2014;4:303\u20138.","journal-title":"Biomed Aging Pathol"},{"key":"3330_CR76","doi-asserted-by":"publisher","unstructured":"John J (2026) Advancements in nano-based drug delivery systems for therapeutics: a comprehensive review. RSC Pharmaceutics. Royal Society of Chemistry (RSC). https:\/\/doi.org\/10.1039\/d5pm00179j","DOI":"10.1039\/d5pm00179j"},{"key":"3330_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/gels10040284","author":"R Binaymotlagh","year":"2024","unstructured":"Binaymotlagh R, Hajareh Haghighi F, Chronopoulou L, Palocci C. Liposome\u2013hydrogel composites for controlled drug delivery applications. Gels. 2024. https:\/\/doi.org\/10.3390\/gels10040284.","journal-title":"Gels"},{"key":"3330_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061771","author":"J Suksiriworapong","year":"2023","unstructured":"Suksiriworapong J, Pongprasert N, Bunsupa S, Taresco V, Crucitti VC, Janurai T, et al. CD44-targeted lipid polymer hybrid nanoparticles enhance anti-breast cancer effect of Cordyceps militaris extracts. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061771.","journal-title":"Pharmaceutics"},{"key":"3330_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/foods13152406","author":"Y Sun","year":"2024","unstructured":"Sun Y, Shen X, Yang J, Tan C. Hyaluronic acid-coated nanoliposomes as delivery systems for fisetin: stability, membrane fluidity, and bioavailability. Foods. 2024. https:\/\/doi.org\/10.3390\/foods13152406.","journal-title":"Foods"},{"key":"3330_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-021-00416-6","author":"N Salari","year":"2021","unstructured":"Salari N, Mansouri K, Valipour E, Abam F, Jaymand M, Rasoulpoor S, et al. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: a systematic review. DARU J Pharm Sci. 2021. https:\/\/doi.org\/10.1007\/s40199-021-00416-6.","journal-title":"DARU J Pharm Sci"},{"key":"3330_CR81","doi-asserted-by":"publisher","unstructured":"Yamamoto F, Ikeda R, Ochiai K, Hirase T, Hayashi N, et al. Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study. Diabetes Therapy [Internet]. 2020;11:523\u201333.  https:\/\/doi.org\/10.6084\/m9.figshare.11418123.","DOI":"10.6084\/m9.figshare.11418123"},{"key":"3330_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/polym15071596","author":"A Yusuf","year":"2023","unstructured":"Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS, MDPI. Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems. Polymers (Basel). 2023. https:\/\/doi.org\/10.3390\/polym15071596.","journal-title":"Polymers (Basel)"},{"key":"3330_CR83","doi-asserted-by":"crossref","unstructured":"Sykiotis GP. Keap1\/Nrf2 signaling pathway. Antioxidants [Internet]. 2021 [cited 2025 Nov 9];10:828. https:\/\/www.mdpi.com\/2076-3921\/10\/6\/828. Accessed 9 Nov 2025","DOI":"10.3390\/antiox10060828"},{"key":"3330_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2018.02.010","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R, Elsevier B.V. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochimica et Biophysica Acta (BBA) - Mol Cell Res. 2018. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.02.010.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Cell Res"},{"key":"3330_CR85","doi-asserted-by":"publisher","unstructured":"Wang Y, Li N, Zeng Z, Tang L, Zhao S, Zhou F, et al. Humanin regulates oxidative stress in the ovaries of polycystic ovary syndrome patients via the Keap1\/Nrf2 pathway. Mol Hum Reprod. 2021. https:\/\/doi.org\/10.1093\/molehr\/gaaa081.","DOI":"10.1093\/molehr\/gaaa081"},{"key":"3330_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081065","author":"HH Arab","year":"2023","unstructured":"Arab HH, Eid AH, Alsufyani SE, Ashour AM, El-Sheikh AAK, Darwish HW, et al. Neuroprotective impact of linagliptin against cadmium-induced cognitive impairment and neuropathological aberrations: targeting SIRT1\/Nrf2 axis, apoptosis, and autophagy. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16081065.","journal-title":"Pharmaceuticals"},{"key":"3330_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09533-2","author":"ME Nady","year":"2024","unstructured":"Nady ME, El-Raouf OMA, El-Sayed ESM. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2\/HO-1 and HIF-1\u03b1\/CTGF\/PAI-1. Mol Biol Rep. 2024. https:\/\/doi.org\/10.1007\/s11033-024-09533-2.","journal-title":"Mol Biol Rep"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03330-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:51:07Z","timestamp":1780390267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3330"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03330-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The\n                      in-vivo\n                      study on mice was conducted in strict accordance with the ARRIVE guidelines (EU Directive 2010\/63\/EU for animals experiment). The study protocol was reviewed and approved by the Ethics Committee of the Faculty of Pharmacy, MSA University. All procedures involving animals were performed with the utmost care to ensure their welfare and to minimize any potential distress. (Approval number PT88\/REC88\/2025P).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"AI technology was used only in editing and language clarity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"166"}}